- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.12.24 | Quipt Home Medical: Vorstand für Betriebsabläufe Patrick Gamble erwirbt Aktien im Wert von 41.633 US-Dollar | 1 | Investing.com Deutsch | ||
| 19.12.24 | Quipt Home Medical stock hits 52-week low at $2.33 | 2 | Investing.com | ||
| 19.12.24 | Quipt Home Medical Corp. (NASDAQ:QIPT) Q4 2024 Earnings Call Transcript | 1 | Insider Monkey | ||
| 17.12.24 | Quipt boosts revenue and customers in Q4 | 1 | The Market Herald Canada | ||
| 16.12.24 | Quipt Home Medical GAAP EPS of -$0.16 misses by $0.05, revenue of $245.9M misses by $7.39M | 1 | Seeking Alpha | ||
| 16.12.24 | Quipt Home Medical Corp.: Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2024 Financial Results | 126 | GlobeNewswire (Europe) | Posts Strong Adjusted EBITDA Margin?1 ?for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024 CINCINNATI, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt"... ► Artikel lesen | |
| QUIPT HOME MEDICAL Aktie jetzt für 0€ handeln | |||||
| 16.12.24 | Quipt Home Medical Corp. - 10-K, Annual Report | - | SEC Filings | ||
| 16.12.24 | Quipt Home Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 15.12.24 | Quipt Home Medical Q4 Earnings Preview | 1 | Seeking Alpha | ||
| 13.12.24 | Earnings Preview For Quipt Home Medical | 2 | Benzinga.com | ||
| 13.12.24 | Exploring Quipt Home Medical's Earnings Expectations | 1 | Benzinga.com | ||
| 04.12.24 | Quipt Home Medical Corp: Quipt to release fiscal 2024 results Dec. 16 | 1 | Stockwatch | ||
| 04.12.24 | Quipt Home Medical Corp. to Announce Fiscal Fourth Quarter and Full Year 2024 Financial Results on December 16, 2024 | 1 | GlobeNewswire (USA) | ||
| 15.11.24 | Quipt Home Medical-Aktie erreicht 52-Wochen-Tief bei 2,55 US-Dollar | 2 | Investing.com Deutsch | ||
| 15.11.24 | Quipt Home Medical stock hits 52-week low at $2.55 | 2 | Investing.com | ||
| 05.09.24 | Quipt Home Medical stock hits 52-week low at $2.6 amid challenges | 1 | Investing.com | ||
| 21.08.24 | Quipt Home Medical stock target cut, maintains buy rating on revenue growth | 1 | Investing.com | ||
| 16.08.24 | Earnings call: Quipt Home Medical sees steady growth in Q3 2024 | 1 | Investing.com | ||
| 16.08.24 | Quipt shares target cut while maintaining buy rating | 1 | Investing.com | ||
| 15.08.24 | Quipt Home Medical stock hits 52-week low at $2.83 | 1 | Investing.com |
Seite:
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 46,650 | +0,09 % | Fresenius Medical Care Aktie: Anerkennung durch starke Leistung! | Die Aktie von Fresenius Medical Care (FMC) verzeichnete am Handelstag einen bemerkenswerten Aufschwung mit einem Kursanstieg von 4,7 Prozent auf 46,53 Euro. Das Handelsvolumen belief sich auf 322.800... ► Artikel lesen | |
| VITA 34 | 4,080 | -1,45 % | Original-Research: Vita 34 AG (von Montega AG): Vita 34 AG | Original-Research: Vita 34 AG - von Montega AG 27.11.2024 / 10:10 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. Für den Inhalt der Mitteilung... ► Artikel lesen | |
| M1 KLINIKEN | 14,550 | -4,59 % | Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: M1 Kliniken AG - from First Berlin Equity Research GmbH 17.12.2024 / 12:00 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer... ► Artikel lesen | |
| BAXTER | 30,805 | -0,42 % | Bear of the Day: Baxter (BAX) | ||
| DAVITA | 161,70 | -0,34 % | DaVita stock soars to all-time high of $169.54 amid robust growth | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,775 | -1,27 % | Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| CYTOSORBENTS | 0,999 | +0,81 % | CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue | Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70% Management will host in-person investor... ► Artikel lesen | |
| SENSEONICS | 1,064 | -0,79 % | Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting | GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable... ► Artikel lesen | |
| UNIVERSAL HEALTH SERVICES | 181,00 | +1,12 % | Here's What to Expect From Universal Health Services' Next Earnings Report | ||
| VIROMED MEDICAL | 2,080 | +0,97 % | Viromed Medical AG: pharmedix-Akquisition abgeschlossen; mwb research empfiehlt spek. KAUFEN | Viromed Medical hat die Übernahme der in Hamburg ansässigen pharmedix GmbH, einem Unternehmen für Gesundheitsprodukte, das sich auf Medizinprodukte, Nahrungsergänzungsmittel und Kosmetika spezialisiert... ► Artikel lesen | |
| DELCATH SYSTEMS | 15,500 | +1,97 % | Delcath Systems - Super Growth Projections | ||
| INTERPACE BIOSCIENCES | 0,805 | 0,00 % | INTERPACE BIOSCIENCES, INC. - 8-K, Current Report | ||
| ORASURE TECHNOLOGIES | 3,760 | +1,62 % | OraSure Technologies, Inc.: OraSure Technologies Acquires Sherlock Biosciences | BETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OTI") (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced... ► Artikel lesen | |
| NUWELLIS, INC | 1,335 | +1,91 % | Nuwellis, Inc.: Nuwellis Regains Compliance with Nasdaq Listing Requirements | MINNEAPOLIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (the "Company" or "Nuwellis") today announced that the Company received formal written notice from The Nasdaq Stock Market... ► Artikel lesen |
Das Unternehmen QUIPT HOME MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,995 Euro und damit +1,53 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QUIPT HOME MEDICAL CORP finden Sie auf Wallstreet Online.
